Autonomic nervous system disorder
MONDO:0001292A disease involving the autonomic nervous system.
Also known as: autonomic nervous disease, autonomic nervous system disease, autonomic nervous system disease or disorder, disease of autonomic nervous system, disease or disorder of autonomic nervous system, disorder of autonomic nervous system, disorder of peripheral autonomic nervous system, disorder of the autonomic nervous system
209 clinical trials for this condition and its sub-types, 59 tagged with Autonomic nervous system disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Autonomic nervous system disorder
-
Dysautonomia 16 trials · 64 incl. sub-types
1 sub-type
- Primary dysautonomia 52 trials Sub-types →
-
Autonomic nervous system neoplasm 0 trials · 60 incl. sub-types
3 sub-types
- Paraganglioma 53 trials · 57 incl. sub-types Sub-types →
- Ganglioneuroma 5 trials Sub-types →
- Sympathetic neurilemmoma 0 trials
-
Sympathetic nervous system disorder 8 trials · 28 incl. sub-types
2 sub-types
- Sympathetic paraganglioma 0 trials · 16 incl. sub-types Sub-types →
- Ganglioneuroma 5 trials Sub-types →
-
Pure autonomic failure 18 trials
-
Autonomic dysreflexia 11 trials
-
Autonomic neuropathy 7 trials · 10 incl. sub-types
2 sub-types
- Diabetic autonomic neuropathy 7 trials
- Horner syndrome 0 trials Sub-types →
-
Baroreflex failure 1 trial
-
Frey syndrome 0 trials
-
Chronic hiccup 0 trials
-
Harlequin syndrome 0 trials
-
1 sub-type
- Parasympathetic paraganglioma 0 trials Sub-types →
Most studied deeper sub-types
-
New combo shows promise for rare adrenal cancers
Disease control OngoingThis study tests whether adding olaparib to the standard chemotherapy temozolomide helps control advanced pheochromocytoma or paraganglioma—rare neuroendocrine tumors that have spread or can't be removed surgically. About 46 adults with these cancers will be randomly assigned to …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New drug cocktail shows promise for rare cancers
Disease control OngoingThis phase 2 trial is testing whether a combination of two drugs, talazoparib and temozolomide, can shrink tumors in people with rare cancers that have spread. The study includes 14 participants with advanced rare solid tumors, such as pheochromocytoma or paraganglioma, who have …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New hope for rare cancers? drug combo shows promise in early trial
Disease control OngoingThis phase 2 study tests two drugs, sunitinib and temsirolimus, in 137 people with advanced rare tumors that have no cure. The goal is to see if these drugs can shrink tumors or slow their growth. Participants take one of the two drugs, and researchers measure how long the cancer…
Phase 2 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Fixing sleep, fortifying hearts: a new trial tests the link
Disease control By invitation onlyThis trial tests whether an insomnia treatment can improve markers of heart health in adults with insomnia and risk factors for cardiovascular disease. Participants receive either a cognitive-behavioral therapy program for insomnia or a sleep education control. The study measures…
Sponsor: Indiana University • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Rare cancer hope: immune drug shows promise in phase 2 trial
Disease control OngoingThis study tested a drug called pembrolizumab in 157 people with rare cancers that had spread or couldn't be removed. The drug works by helping the body's immune system attack the cancer. The main goal was to see how many patients were alive and their cancer hadn't grown after 27…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Immunotherapy duo takes on rare tumors
Disease control OngoingThis phase 2 trial is testing a combination of two immunotherapy drugs, nivolumab and ipilimumab, in 798 people with over 50 types of rare cancers. The goal is to see if these drugs can shrink tumors by helping the immune system attack cancer cells. Participants receive the drugs…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Hope for rare brain disease: new drug aims to slow MSA
Disease control OngoingThis study tests an experimental drug called Lu AF82422 in 64 people with multiple system atrophy (MSA), a rare and serious brain disease. The goal is to see if the drug can slow down the worsening of symptoms like movement problems and daily living difficulties. Participants rec…
Phase 2 • Sponsor: H. Lundbeck A/S • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New hope for rare tumors: drug may slow cancer growth
Disease control OngoingThis study tests a drug called lanreotide in 10 people with advanced or metastatic paraganglioma or pheochromocytoma, rare tumors that release hormones. The goal is to see if lanreotide can slow tumor growth compared to before treatment. Participants receive injections every 4 we…
Phase 2 • Sponsor: Antonio Fojo • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Blood pressure drug shows promise in slowing Parkinson's progression
Disease control OngoingThis study looks at whether terazosin, a drug usually used for high blood pressure, can slow the progression of Parkinson's disease. Researchers are tracking changes in heart and brain scans of 15 people who are either in early stages or at high risk for Parkinson's. The goal is …
Phase 2 • Sponsor: Cedars-Sinai Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New hope for rare tumors? drug axitinib tested in small trial
Disease control OngoingThis phase II trial tests the drug axitinib in 6 adults with metastatic or inoperable pheochromocytoma or paraganglioma, rare tumors of the adrenal glands or nerve tissue. Axitinib works by blocking blood vessel growth that feeds tumors. The main goal is to see how many patients'…
Phase 2 • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Radioactive drug lutathera tested in teens with rare cancers
Disease control OngoingThis study is testing a radioactive drug called Lutathera in teenagers aged 12 to 17 who have rare tumors of the digestive system or adrenal glands. The goal is to see if the drug is safe and how much radiation reaches organs. Eleven teens are taking part, and researchers are wat…
Phase 2 • Sponsor: Advanced Accelerator Applications • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Newborn screening study aims to catch rare diseases at birth
Diagnosis OngoingThis study offers voluntary screening for newborns in North Carolina to detect a wide range of rare health conditions early. Using a small blood sample already collected at birth, the program tests for dozens of disorders, including spinal muscular atrophy, cystic fibrosis, and m…
Sponsor: RTI International • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
New scan could spot hidden tumors more accurately
Diagnosis OngoingThis study tests whether a new type of PET/CT scan, using a radioactive tracer called 68Ga-DOTATOC, can find neuroendocrine tumors (NETs) and similar tumors more safely and accurately than current imaging methods. About 800 people with known or suspected NETs will receive the sca…
Sponsor: British Columbia Cancer Agency • Aim: Diagnosis
Last updated Jun 27, 2026 12:31 UTC
-
New scan may improve detection of childhood nerve tumors
Diagnosis OngoingThis study involves 20 children and young adults with neuroendocrine tumors (like neuroblastoma) that have spread. Researchers are testing whether a special PET/CT scan using a radioactive tracer called 68Ga-DOTATATE can find tumors better than the standard MIBG scan. The goal is…
Early phase 1 • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 12:02 UTC
-
Quick Needle-Free test could spot long COVID
Diagnosis By invitation onlyThis study tests a new, non-invasive diagnostic method for long COVID. Researchers will use a single-session bioelectrical assessment to detect patterns linked to viral persistence in 50 adults with long COVID. The goal is to see if this approach can reliably identify ongoing vir…
Sponsor: Oncology Center,Ministry Of Heath,Uzbekistan • Aim: Diagnosis
Last updated Jun 27, 2026 08:11 UTC
-
Can Full-Body scans spot cancer early in High-Risk families?
Diagnosis OngoingThis study is testing whether whole body MRI scans can help find cancers early in children and adults with Li-Fraumeni syndrome, a genetic condition that greatly raises cancer risk. About 150 participants will receive annual whole body MRI scans for four years to see if they keep…
Sponsor: Dana-Farber Cancer Institute • Aim: Diagnosis
Last updated Jun 27, 2026 08:08 UTC
-
Which scan spots hidden tumors best? new study aims to find out
Diagnosis OngoingThis study compares three different PET/CT scans (68Ga-HA-DOTATATE, 18F-DOPA, and 18F-FDG) in 50 people with metastatic neuroendocrine tumors. The goal is to see if all tumors show up on the standard scan or if some are missed, which could change treatment. Participants will get …
Phase 2 • Sponsor: University of Alberta • Aim: Diagnosis
Last updated Jun 27, 2026 07:58 UTC
-
Can early botox shots save bladders after spinal cord injury?
Prevention By invitation onlyResearchers are testing whether injecting Botox into the bladder wall soon after a spinal cord injury can prevent lasting bladder damage. The study enrolls 10 adults with recent injuries at T6 or higher. Half receive Botox injections and half receive saline sham injections. The t…
Early phase 1 • Sponsor: University of Washington • Aim: Prevention
Last updated Sep 11, 2026 00:00 UTC
-
New drug aims to stop the dizziness of standing up
Symptom relief OngoingThis study tests a new drug called CST-3056 in 12 adults with neurogenic orthostatic hypotension (a sharp drop in blood pressure when standing) caused by Parkinson's disease or pure autonomic failure. The goal is to see if the drug can improve blood pressure and reduce symptoms l…
Phase 2 • Sponsor: CuraSen Therapeutics, Inc. • Aim: Symptom relief
Last updated Aug 30, 2026 00:00 UTC
-
Can a 10-Minute breathing app tame migraines?
Symptom relief By invitation onlyThis study tests an 8-week app-based breathing program that uses heart rate feedback to help people with chronic migraine. Thirty adults will use the app daily for 10 minutes, and researchers will track changes in migraine frequency and psychological well-being. The goal is to se…
Sponsor: Arizona State University • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
Could a common constipation drug help diabetics?
Symptom relief OngoingThis study tests whether linaclotide (Linzess) can improve bowel movement frequency in people with type 2 diabetes who have chronic constipation. About 23 participants will receive either the drug or a placebo for two weeks, then switch after a break. The goal is to see if the dr…
Phase 4 • Sponsor: Texas Tech University Health Sciences Center, El Paso • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Brain zaps and Self-Taught moves: a new way to learn?
Knowledge-focused OngoingThis study looks at whether a type of brain stimulation called rTMS, combined with letting people choose when to get feedback, can improve how healthy young adults learn a motor task. 72 participants will be split into groups receiving different types of stimulation or a fake ver…
Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated Sep 21, 2026 17:00 UTC
-
Can your smartwatch predict a stress breakdown?
Knowledge-focused By invitation onlyThis study will use wearable devices like heart rate monitors and sleep trackers to see how financial stress and news affect your body. Researchers will follow 2,500 adults remotely, collecting data on heart rate, sleep, and stress levels. The goal is to create AI tools that can …
Sponsor: Truway Health, Inc. • Aim: Knowledge-focused
Last updated Aug 27, 2026 00:00 UTC
-
Wearable ECG patch could unlock hidden heart risks
Knowledge-focused By invitation onlyThis study is testing whether a wearable ECG patch, combined with AI analysis, can help doctors identify a wide range of heart conditions and risks from a single recording. The Cor360 system looks at many aspects of heart health at once, such as heart failure, rhythm problems, an…
Sponsor: Peerbridge Health, Inc • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
Reading the Body's stress signal from the skin
Knowledge-focused By invitation onlyThis study is testing a new, non-invasive way to measure the body's sympathetic nervous system — the part that controls the 'fight-or-flight' response. Researchers will record nerve activity from the skin of about 1,000 people, including healthy volunteers and those with conditio…
Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
Can teaching couples about money change who calls the shots on having kids?
Knowledge-focused OngoingThis trial tests whether a six-session financial literacy and gender-equality program for married couples in rural India can change how women and men think about reproductive decision-making for younger generations. Researchers ask participants who should have the main say in whe…
Sponsor: Technical University of Munich • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC
-
Could a frayed nerve explain long COVID symptoms? new study investigates
Knowledge-focused OngoingThis study looks at why some people develop POTS (a condition causing rapid heartbeat and dizziness) after COVID-19. Researchers think a part of the nervous system that normally fights inflammation may not work well in these patients. They will compare 150 adults with and without…
Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
Can sound waves tame the autonomic nervous system?
Knowledge-focused By invitation onlyThis study explores whether low-intensity focused ultrasound (LIFU) aimed at specific brain regions can influence how the body controls automatic functions like heart rate and blood pressure. Researchers will apply LIFU or a sham (fake) version to 80 volunteers and measure change…
Sponsor: Virginia Polytechnic Institute and State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Healthy volunteers needed to map the Body's 'Autopilot' system
Knowledge-focused By invitation onlyThis study aims to better understand the autonomic nervous system (ANS), which controls things like heart rate and breathing without us thinking about it. Researchers will use simple, noninvasive tests (like cold water and deep breathing) to measure how the ANS responds in 48 hea…
Sponsor: Northwell Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Hidden heart risk in kids with diabetes: new study investigates
Knowledge-focused OngoingThis study examines how common cardiac autonomic neuropathy (nerve damage affecting the heart) is in children and teens with type 1 diabetes. Researchers will monitor 75 participants using heart tests and check if longer diabetes duration or poor blood sugar control raises the ri…
Sponsor: Marwa Abouelela Abd Elsalam • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
War wounds may trigger hidden heart risks, new study reveals
Knowledge-focused By invitation onlyThis study looks at how serious combat injuries affect the long-term health of U.S. military members. Researchers will measure heart function, sleep quality, and stress-related body signals in 200 injured service members. The goal is to understand links between injury severity, s…
Sponsor: Uniformed Services University of the Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Reading to babies: a surprising boost for tiny hearts and brains?
Knowledge-focused OngoingThis pilot study from Tulane University tests whether a mother reading aloud to her newborn can positively affect the baby's autonomic nervous system. One healthy newborn and mother will have their heart activity measured during reading sessions. The goal is to see if live readin…
Sponsor: Tulane University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Childhood cancer Survivors' heart health under the microscope
Knowledge-focused CancelledThis study was designed to understand heart rate and sleep issues in adults who survived childhood cancer. Researchers planned to use a smartphone app and wearable device to compare survivors with their siblings. The goal was to identify who is most at risk and develop ways to pr…
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Could a common heart pill delay Parkinson's? small study hints at possibility
Knowledge-focused OngoingThis study looks at whether carvedilol, a drug used for heart failure, can reverse early heart changes seen in people with a sleep disorder that puts them at high risk for Parkinson's disease. Fifteen participants with REM sleep behavior disorder or reduced sense of smell will ta…
Phase 2 • Sponsor: Michele Tagliati, MD • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Scientists dig into the Body's wiring after COVID: what causes POTS?
Knowledge-focused OngoingThis study looks at what happens in the body to cause POTS and dysautonomia after viral infections, including COVID-19. About 100 women will give a blood sample and share medical records. Researchers will study immune system markers to find clues that could lead to better diagnos…
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Vagus nerve study for autism withdrawn before starting
Knowledge-focused CancelledThis study planned to test vagus nerve stimulation (VNS) in children and adults with autism and developmental disabilities to see if it could improve behavior, thinking, and body rhythms. Participants would have chosen 1 to 3 months of daily VNS and completed monthly check-ins. T…
Sponsor: New York State Institute for Basic Research • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
POTS brain fog targeted in new drug study
Knowledge-focused OngoingThis early-phase study tests whether a single dose of modafinil, a drug that promotes wakefulness, can improve concentration and mental clarity in people with Postural Tachycardia Syndrome (POTS). About 20 adults diagnosed with POTS will take the drug and then complete computer-b…
Early phase 1 • Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Silent tumors may still harm the heart, new study warns
Knowledge-focused By invitation onlyThis study looks at people with rare adrenal tumors (pheochromocytomas and paragangliomas) that do not produce excess hormones. Researchers want to see if these 'silent' tumors still cause heart problems, blood pressure changes, or metabolic issues like diabetes and high choleste…
Sponsor: Laikο General Hospital, Athens • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
Can a glass of water or a change in posture spike your eye pressure?
Knowledge-focused By invitation onlyThis study looks at how changing your body position or drinking water can cause temporary spikes in eye pressure. Researchers will measure these changes in healthy volunteers and in people with glaucoma or autonomic dysfunction. The goal is to better understand what challenges th…
Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Brain insulin study seeks healthy volunteers
Knowledge-focused PausedThis study looks at how insulin in the brain changes blood flow and nerve signals in healthy adults aged 18-45. Researchers will measure blood flow in the brain and legs, as well as nerve activity. The goal is to understand basic body functions, not to treat any disease.
Early phase 1 • Sponsor: University of Missouri-Columbia • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
New imaging method could spot hidden cancers
Knowledge-focused OngoingThis pilot study is testing a radioactive antibody called 124I-Humanized 3F8 to see how it travels through the body and attaches to tumors in people with melanoma, neuroblastoma, or sarcoma. Seven participants will receive the antibody and then have PET/CT scans at several time p…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Could POTS be an autoimmune disorder? new study investigates
Knowledge-focused By invitation onlyThis study at Vanderbilt University Medical Center is looking at whether people with postural tachycardia syndrome (POTS) have higher levels of certain immune proteins that might affect their symptoms. Researchers will measure these proteins in blood samples and test how the hear…
Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Could antibodies be the key to understanding POTS?
Knowledge-focused OngoingThis study compares blood samples from 212 people with and without Postural Orthostatic Tachycardia Syndrome (POTS) to see if those with POTS have higher levels of certain antibodies. Researchers also want to know if these antibodies are more common in people whose POTS started a…
Sponsor: Vanderbilt University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Heart risks in adrenal tumor patients under the microscope
Knowledge-focused By invitation onlyThis study follows 150 patients with functional adrenal tumors to see how their heart and blood pressure change before and after surgery. Researchers will use heart ultrasounds and blood pressure monitoring to understand recovery and risks. The goal is to help doctors choose bett…
Sponsor: Peking University First Hospital • Aim: Knowledge-focused
Last updated Jun 26, 2026 19:09 UTC